Last reviewed · How we verify

NCT04631497

Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19

Completed Last updated 6 June 2022
What this trial tests

trial testing test in Depression in 46 participants. Completed in 31 December 2021.

Timeline
1 July 2020
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorJagiellonian University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment46
Start date1 July 2020
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Jagiellonian University

Who can join

Adults 18 to 70, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Medical personnel working in the Intensive Care Unit will be examined by means of tests. Their aim is to check how work-related stress in a potentially lethal threat affects the occurrence of depression, stress, anxiety and sleep disorders. We also want to check whether people working in such extremely difficult conditions show no greater interest in death.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. COVID 19 pandemic challenges and their management: A review of medicines, vaccines, patents and clinical trials with emphasis on psychological health issues.
    Mohapatra S, Ayash Kumar P, Farooq U, Jain P, et al · · 2022 · cited 3× · PMID 35645588 · DOI 10.1016/j.jsps.2022.05.004

Verify or expand the search:

Other trials of test

Trials testing the same drug.

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Jagiellonian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04631497.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing